NAMPT and lymphoma: Notably, compound 3 induced the regression of lymphoma in combination with Daporinad (FK866 or APO866), a metabolic inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), which is an enzyme involved in the biosynthesis of nicotinamide adenine dinucleotide (NAD+) from nicotinamide.